[1]
|
American Diabetes Association (ADA) (2002) Implications of the Diabetes Control and Complications Trial. Diabetes Care, 25, S25-S27. http://dx.doi.org/10.2337/diacare.25.2007.S25
|
[2]
|
The Diabetes Control and Complications Trial Research Group (1993) The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine, 329, 977-986. http://dx.doi.org/10.1056/NEJM199309303291401
|
[3]
|
IDF (2003) International Diabetes Federation: Diabetes Atlas. IDF.
http://www.idf.org/sites/default/files/IDF_Diabetes_Atlas_2ndEd.pdf
|
[4]
|
Whiting, D.R., Guariguata, L., Weil, C. and Shaw, J. (2011) IDF Diabetes Atlas: Global Estimates of the Prevalence of Diabetes for 2011 and 2030. Diabetes Research and Clinical Practice, 94, 311-321.
http://dx.doi.org/10.1016/j.diabres.2011.10.029
|
[5]
|
The Diabetes Control and Complications Trial Research Group (1993) The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England Journal of Medicine, 329, 977-986. http://dx.doi.org/10.1056/NEJM199309303291401
|
[6]
|
UK Prospective Diabetes Study (UKPDS) (1998) Group. Intensive Blood-Glucose Control with Sulphonylureas or Insulin Compared with Conventional Treatment and Risk of Complications in Patients with Type 2 Diabetes (UKPDS 33). The Lancet, 352, 837-853. http://dx.doi.org/10.1016/S0140-6736(98)07019-6
|
[7]
|
American Diabetes Association (2002) Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care, 25, 528-532.
|
[8]
|
Sharon, H., Judith, F. and Catherine, C. (2004) Poor Control of Risk Factors for Vascular Disease among Adults with Previously Diagnosed Diabetes. The Journal of the American Medical Association, 291, 335-342.
http://dx.doi.org/10.1001/jama.291.3.335
|
[9]
|
Al-Elq, A.H. (2009) Current Practice in the Management of Patients with Type 2 Diabetes Mellitus in Saudi Arabia. Saudi Medical Journal, 30, 1551-1556.
|
[10]
|
Alfadda, A. and Abdulrahman, K. (2006) Assessment of Care for Type 2 Diabetic Patients at the Primary Care Clinics of a Referral Hospital. Journal of Family & Community Medicine, 13, 13-18.
|
[11]
|
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee (2013) Target for Glycemic Control. Canadian Journal of Diabetes, 37, S31-S34.
|
[12]
|
American Diabetes Association (2014) Standards of Medical Care in Diabetes. Diabetes Care, 37, S14-S80.
http://dx.doi.org/10.2337/dc14-S014
|
[13]
|
Sarah, J.B., Soma, S.N., Margaret, J., Jeremy, M., Shiva, S. and Charles, M. (2004) Adequacy of Glycemic, Lipid, and Blood Pressure Management for Patients with Diabetes in a Managed Care Setting. Diabetes Care, 27, 694-698.
http://dx.doi.org/10.2337/diacare.27.3.694
|
[14]
|
Al-Nozha, M.M., Al-Maatouq, M.M., Al-Mazrou, Y.Y., Al-Harth S.S., Arafah, M.R., Khalil, M.Z., et al. (2004) Diabetes Mellitus in Saudi Arabia. Saudi Medical Journal, 25, 1603-1610.
|
[15]
|
Charpentier, G., Genes, N., Vaur, L., Amar, J., Clerson, P., Cambou, J.P. and Gueret, P. (on Behalf of the ESPOIR Diabetes Study Investigators) (2003) Control of Diabetes and Cardiovascular Risk Factors in Patients with Type 2 Diabetes: A National Wide French Survey. Diabetes & Metabolism, 29, 152-158.
http://dx.doi.org/10.1016/S1262-3636(07)70022-8
|
[16]
|
Yoshiharu, T., Toshiharu, I., Kana, M., Toru, E. and Azuma, K. (2008) Predictors of Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus. Metabolism—Clinical and Experimental, 57, 453-457.
http://dx.doi.org/10.1016/j.metabol.2007.11.004
|
[17]
|
Kellow, N.J., Savige, G.S. and Khalil, H. (2011) Predictors of Poor Glycaemic Control during the Initial Five Years Post-Diagnosis in Rural Adults with Type 2 Diabetes. Australian Journal of Rural Health, 19, 267-274.
http://dx.doi.org/10.1111/j.1440-1584.2011.01222.x
|